Back to Press Releases

INSIGHTEC’S EXABLATE SELECTED AS ONE OF CIRSE 2014’S HOT TOPICS OF THE YEAR

September 11, 2014
icons for web-onco.png

Haifa, Israel [September 11th, 2014] -- INSIGHTEC, a world leader in MR-guided Focused Ultrasound (MRgFUS) is proud to announce that its ExAblate® technology was selected as one of the 2014 Cardiovascular and Interventional Radiological Society of Europe’s hot topics of the year.

 

CIRSE is the world’s largest Interventional Radiology congress and will host more than 5,000 doctors, researchers and medical professionals, mainly radiologists and interventional radiologists. One of the main discussions will be around whether MRgFUS technology presents benefits beyond those offered by more established ablation modalities.

 

INSIGHTEC fully believes that its MRgFUS is a technology that is revolutionizing medicine as we know it. Current clinical evidence shows high success rates as well as a high safety profile. All these clear advantages drove leading physicians in many prominent medical facilities around the world to adopt INSIGHTEC’s ExAblate® offering.

 

Currently INSIGHTEC’s technology is already used to treat uterine fibroids, bone metastases, brain tremor disorders (still investigational in the USA), and more. In addition, researchers around the world are currently utilizing INSIGHTEC’s ExAblate® technology to treat liver cancer, pancreatic cancer, prostate cancer, and breast cancer under research protocols. Treatments of additional indications are expected to be pursued in the future.

 

INSIGHTEC will sponsor a Satellite Symposium: "MR guided Focused Ultrasound from Head to Toe. The symposium will be held Sept. 14, 13:00-14:00, in Auditorium 5. The session is going to be moderated by Mario Bezzi, MD and is going to be an especially interesting one as it will present clinical case studies shared by INSIGHTEC customers:

  • Tumour Ablation: Breast, Pancreas and Prostate - A. Napoli, MD (Rome, Italy)
  • Pain Palliation in Bone: Tumours and Facet - M. Düx, MD (Frankfurt, Germany)
  • Uterine Fibroids MRgFUS: Familiar Concept, New Evidence, MD - M. Matzko (Dachau, Germany) 

 

In addition, CIRSE’s Scientific Program Deputy Chairperson, Christopher Binkert, will lead a roundtable discussion on future applications of the technology.

 

We invite you to attend the session as well as visit us at the INSIGHTEC booth (#95) to learn more about our unique non-invasive technology for treating a variety of inner-body clinical indications.

Please fill in the following details and we will get in touch with you. (* Required)

agreement Error

Thank You!

Thank you for contacting us! We will get back to you shortly.

Thank You!

This site is brought to you by INSIGHTEC, © 2018 INSIGHTEC Ltd. All rights reserved.

NGSoft logo